Agah Abdullah Kahramanlar

Dr. Agah Abdullah Kahramanlar

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
AKAgah Abdullah Kahramanlar
Agah Abdullah Kahramanlar
HOHabip Burak Ozgodek
Habip Burak Ozgodek
RIRamazan Ince
Ramazan Ince
BYBulent Yavuzer
Bulent Yavuzer
OAOzlem Admis
Ozlem Admis
HSHalis Suleyman
Halis Suleyman
Background: Amiodarone is a widely used class III antiarrhythmic agent, but its use can lead to peripheral neuropathy mediated by mitochondrial dysfunction, oxidative stress, and neuroinflammatory injury, while effective preventive options remain limited. Agents that support mitochondrial energy metabolism, sustain redox balance, and modulate inflammation, including adenosine triphosphate (ATP), melatonin, and thiamine pyrophosphate (TPP), may counteract these mechanisms; however, their relative neuroprotective potential in amiodarone-induced neuropathy remains unclear. This study aimed to comparatively evaluate the effects of ATP, melatonin, and TPP on amiodarone-induced peripheral neuropathy and neuropathic pain in rats. Methods: Thirty male albino Wistar rats were assigned to five groups: healthy; amiodarone (50 mg/kg/orally); amiodarone + ATP (5 mg/kg/intraperitoneally); amiodarone + melatonin (10 mg/kg/orally); or amiodarone + TPP (20 mg/kg/intraperitoneally). Treatments were given once daily for 14 days. Oxidative stress indices (malondialdehyde (MDA), total glutathione (tGSH), superoxide dismutase (SOD), catalase (CAT)) and proinflammatory cytokines (tumor necrosis factor-alpha (TNF-α), interleukin-1 Beta (IL-1β), interleukin-6 (IL-6)) were quantified in sciatic nerve by Enzyme-Linked Immunosorbent Assay (ELISA). Paw withdrawal thresholds were measured with the Randall-Selitto test before and after treatment. Histopathology was performed using Hematoxylin-eosin staining. Results: Amiodarone exposure resulted in pronounced elevations in MDA and proinflammatory cytokine levels, accompanied by significant reductions in tGSH, SOD, CAT activities, and paw withdrawal thresholds. ATP, melatonin and TPP ameliorated these alterations to varying degrees. Among them, TPP provided the most robust antioxidant and anti-inflammatory effects, followed by ATP and melatonin. Histopathological examination confirmed most severe axonal degeneration, interstitial edema and Schwann cell proliferation in the amiodarone group, with substantial amelioration in the TPP-treated rats. Conclusions: Amiodarone induces neuropathic pain through oxidative and inflammatory injury to peripheral nerves. TPP exhibited superior neuroprotective efficacy compared with ATP and melatonin, highlighting its potential as a candidate therapeutic agent for amiodarone-related neuropathy. Further clinical research is warranted to support translational application of these findings.

22 February 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
HOHabip Burak Ozgodek
Habip Burak Ozgodek
RIRamazan Ince
Ramazan Ince
AKAgah Abdullah Kahramanlar
Agah Abdullah Kahramanlar
BYBulent Yavuzer
Bulent Yavuzer
ESEsra Tuba Sezgin
Esra Tuba Sezgin
HSHalis Suleyman
Halis Suleyman
Background/Objectives: Linezolid is an oxazolidinone antibiotic whose prolonged use is associated with peripheral neuropathy, hyperlactatemia, and metabolic acidosis. These adverse effects are primarily linked to the inhibition of mitochondrial protein synthesis, respiratory chain dysfunction, and oxidative stress. Given the central role of impaired energy metabolism and redox imbalance in drug-induced peripheral neuropathy, therapeutic strategies targeting mitochondrial function are of particular interest. Accordingly, this study aimed to comparatively evaluate the effects of adenosine triphosphate (ATP), coenzyme Q10 (CoQ10), pyridoxine, and thiamine pyrophosphate (TPP) on linezolid-induced peripheral neuropathic pain in rats. Methods: Sixty male albino Wistar rats were assigned to ten groups: healthy (HG); ATP-only (ATPG, 5 mg/kg, intraperitoneally); CoQ10-only (CQ10G, 10 mg/kg, orally); pyridoxine-only (PDXG, 50 mg/kg, orally); TPP-only (TPPG, 20 mg/kg, intraperitoneally); linezolid-only (LZDG, 125 mg/kg, orally); linezolid+ATP (ATLG); linezolid+CoQ10 (CQLG); linezolid+pyridoxine (PXLG); and linezolid+TPP (TPLG). Treatments were administered once daily for ATP, CoQ10, and TPP, and twice daily for linezolid and pyridoxine for 14 days. Oxidative stress indices (MDA, tGSH, SOD, CAT) were quantified in the sciatic nerve using ELISA. Serum lactate dehydrogenase (LDH) activity and blood lactate levels were determined to evaluate metabolic disturbances. Mechanical paw withdrawal thresholds were measured using the Randall–Selitto test both before and after treatment. Results: Linezolid significantly reduced paw withdrawal thresholds and induced oxidative stress, antioxidant depletion, increased LDH activity, and hyperlactatemia. Co-treatment with ATP and CoQ10 attenuated oxidative stress but did not significantly improve linezolid-induced reductions in nociceptive thresholds. In contrast, pyridoxine partially alleviated linezolid-induced neuropathic pain and improved biochemical parameters. Notably, TPP exerted the most robust protective effect, preserving nociceptive thresholds and effectively normalizing oxidative stress and metabolic indices. Conclusions: These findings identify TPP as a promising therapeutic strategy for mitigating linezolid-induced peripheral neuropathic pain by targeting mitochondrial energy metabolism and pyruvate–lactate homeostasis.

Verified
Journal Article
Open access
PDF file
RIRamazan Ince
Ramazan Ince
HOHabip Burak Ozgodek
Habip Burak Ozgodek
AKAgah Abdullah Kahramanlar
Agah Abdullah Kahramanlar
NYNurinisa Yücel
Nurinisa Yücel
CSCengiz Sarıgül
Cengiz Sarıgül
HSHalis Suleyman
Halis Suleyman
Surgical trauma triggers oxidative and inflammatory responses that contribute to postoperative complications. Although the antioxidant and anti-inflammatory effects of ketamine have been reported, the impact of anesthesia duration on these mechanisms remains unclear. Forty-two male Wistar rats were randomized into healthy control (HG), ketamine only (KET; 60 mg/kg, i.p.), or laparotomy plus ketamine with 0–4 additional ketamine doses at 20 min intervals (KET + L, KET + L1–L4). At 24 h, levels of MDA, tGSH, SOD, CAT, IL-1β, IL-6, TNF-α, adrenaline and noradrenaline were measured in tail-vein blood. One-way ANOVA with Tukey’s post hoc test was used. Laparotomy under single-dose ketamine increased MDA and pro-inflammatory cytokines and decreased tGSH, SOD, CAT, ADR, and NDR versus HG and KET (all p < 0.001). After laparotomy, repeated ketamine dosing produced graded decreases in MDA and cytokines and increases in tGSH, SOD, CAT, ADR, and NDR toward control levels; effects were most pronounced in KET + L4 (all p < 0.001). Ketamine alone did not differ significantly from HG. In rats, ketamine modulates postoperative biological stress in a duration-dependent manner; prolonging anesthesia reduces oxidative–inflammatory load and restores catecholaminergic tone. These findings strongly support revisiting dose–duration protocols and underscore the need for mechanistic and clinical studies.

2 June 2025 in Pakistan Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
KKKamber Kasali
Kamber Kasali
GSGamze Nur Cimilli Senocak
Gamze Nur Cimilli Senocak
ADAysenur Dostbil
Aysenur Dostbil
EYEmsal Pinar Topdagi Yilmaz
Emsal Pinar Topdagi Yilmaz
AKAgah Abdullah Kahramanlar
Agah Abdullah Kahramanlar
SASabri Selcuk Atamanalp
Sabri Selcuk Atamanalp
Objectives: The mother-infant relationship is a magical process that begins with conception and strengthens when the mother feels the baby’s movements. This special bond, formed during pregnancy, is shaped by the parent’s emotions, perceptions, and behaviors toward the fetus. Research shows that heightened maternal anxiety during pregnancy and childbirth affects maternal behavior and impairs mother-infant bonding. While studies suggest that delivery mode influences maternal anxiety and postpartum depression, results often vary due to group differences and confounding factors. Although delivery mode may impact postpartum depression and mother-infant bonding, direct research on its specific effects remains limited. Methods: In this prospective study, a structured questionnaire was administered to 208 women in six months period between March, 2024 and September, 2024 in Ataturk University Faculty of Medicine Research Hospital. The survey aimed to gather participants’ demographic information and assess their mother-infant bonding and postpartum depression statuses. The Mother-infant bonding scale (MIBS) and the Edinburgh postpartum depression scale (EPDS) were used for data collection. Results: The analysis determined that delivery mode did not significantly affect the EPDS total score and MIBS total score relation. The indirect effect was calculated as 0.001±0.001 (CI: -0.003 to 0.001, β =-0.002, p=0.635), the direct effect as -0.170±0.228 (CI: -0.618 to 0.277, β =-0.127, p=0.063), and the total effect as -0.036±0.019 (CI:-0.074 to 0.001, β=-0.129, p = 0.059). Conclusion: This study showed that mode of delivery did not affect the postnatal maternal depression on mother-infant bonding. doi: https://doi.org/10.12669/pjms.41.6.11759 How to cite this: Kasali K, Cimilli Senocak GN, Dostbil A, Yilmaz EPT, Kahramanlar AA, Atamanalp SS. The mediating role of delivery mode on postpartum maternal depression and mother-infant bonding. Pak J Med Sci. 2025;41(6):1701-1707. doi: https://doi.org/10.12669/pjms.41.6.11759 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

28 December 2024 in Atatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi
Verified
Journal Article
Open access
ODOmer Doymus
Omer Doymus
OBOsman Bagbanci
Osman Bagbanci
MOMehmet Sercan Orbak
Mehmet Sercan Orbak
AKAgah Abdullah Kahramanlar
Agah Abdullah Kahramanlar
FAFatma Akin
Fatma Akin
ITI. Tor
I. Tor
Objective: Central venous catheters are mainly used for safe fluid infusion, total parenteral nutrition, and evaluation of hemodynamic parameters. Complications related to central venous access can occur during insertion, after insertion or during catheter maintenance. The aim of this study was to investigate the demographic data and the presence of catheter-related complications in pediatric patients with central venous catheters in our hospital. Methods: This study retrospectively reviewed demographic data and the presence of catheter-related complications in pediatric patients with central venous catheters in our hospital from June 1, 2019, to February 28, 2023. Results: Patients who underwent central venous catheterisation in our hospital between June 2020 and February 2023 were included in the study. When the demographic data of the patients were evaluated, 141 (57.8%) of our patients were male and 103 (42.2%) were female, and there was no statistically significant difference between the groups. In the femoral group, catheterisation of the right femoral vein was preferred more than the left vein (72.2%-27.7%), whereas in the jugular-subclavian group, the right internal jugular vein was preferred more than other sites. The risk of infection was statistically higher in the femoral group compared to the subclavian group. Conclusion: In clinical practice, we think that the risk of complications can be reduced in central venous catheter applications in pediatric patients by experienced personnel by complying with asepsis/antisepsis conditions and using appropriate imaging devices.

13 November 2025 in Clinics
Verified
Journal Article
Open access
IAIrem Ateş
Irem Ateş
ELESRA LALOĞLU
ESRA LALOĞLU
NKNeslihan Küçün
Neslihan Küçün
SOSevilay Ozmen
Sevilay Ozmen
SYSerkan YILDIRIM
Serkan YILDIRIM
IBİsMail Bolat
İsMail Bolat
Peripheral nerve injuries are particularly important in terms of their frequency and complications. The purpose of this experimental study was to investigate the neuroprotective effects of pregabalin and methylprednisolone administered at different doses and in combination in an axonotmesis model and to establish whether pregabalin can represent an alternative to methylprednisolone. Fifty-six adult male Sprague-Dawley rats were assigned to control, sham (axonotmesis only), axonotmesis + pregabalin 30 mg/kg (low dose), axonotmesis + pregabalin 60 mg/kg (high dose), axsonotmezis + 1 mg/kg methylprednisolone, axonotmesis + pregabalin 30 mg/kg + 1 mg/kg methylprednisolone (low-dose combination), and axonotmesis + pregabalin 60 mg/kg + 1 mg/kg methylprednisolone (high-dose combination) groups. Following axonotmesis, the treatment groups received oral treatment once daily for one week. Sciatic functional index, electromyography, biochemical (NGF, TGF-β, CNTF, MBP), immunohistochemical, histomorphological and immunofluorescence analyses were performed to assess the neuroprotective effects of the treatments. Immunohistochemical, electrophysiological, and biochemical analyses demonstrated that the separate or combined use of pregabalin and methylprednisolone may have positive effects on nerve regeneration. Low-dose pregabalin and methylprednisolone alone exhibited similar effects on peripheral nerve regeneration and functional healing. Pregabalin may represent an alternative to steroids due to its fewer side effects. Although direct pain behavior assessment was not performed in this study, the effect of pregabalin on neuropathic pain may be additionally beneficial in combined use. These results demonstrate that pregabalin offers comparable neuroregenerative effects to methylprednisolone, with combination therapy proving superior. This positions pregabalin as a promising steroid-sparing agent for peripheral nerve injury, warranting further clinical investigation.